over the years, i�ve talked to reporters who are solidly addicted to obfuscations. like any addict, they have an army of excuses to rationalize their behavior.
.
.: "fremanezumab for the preventive treatment of chronic migraine."
.ai-based software may help predict risk of dementia
.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
embolization “cuts off the blood supply to a certain part of the body,” according to the national institutes of health.
.